{
    "nctId": "NCT02924584",
    "briefTitle": "Clinical Outcome Of Hormonal Receptor Positive, Her-2 Negative Breast Cancer In Taiwan",
    "officialTitle": "The Treatment For Recurrent Female Breast Cancer After Initial Endocrine Therapy Among Taiwanese Population",
    "overallStatus": "COMPLETED",
    "conditions": "ER/PR(+), Her2(-) Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 1,
    "primaryOutcomeMeasure": "clinical use of aromatase inhibitors in breast cancer",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* hormonal receptor positive, human epidermal growth factor receptor 2 negative breast cancer\n\nExclusion Criteria:\n\n-",
    "sex": "ALL",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}